
ZYMUTESTâ„¢ HIA IgG
Price:
$999.00
Product DescriptionFor In Vitro Diagnostic Use.
ZYMUTEST™ HIA IgG is an ELISA for detecting IgG antibodies against Platelet Factor 4 (PF4)/heparin complexes in human plasma or serum. IgG-specific assay provides higher specificity for clinically significant (pathogenic) HIT antibodies compared to polyspecific IgGAM screening. For diagnosis and risk assessment of Heparin-Induced Thrombocytopenia (HIT) and HIT with Thrombosis (HITT). Use in conjunction with clinical scoring (4Ts score) and functional assays (SRA, HIPA) for definitive HIT diagnosis. FDA 510(k) cleared. CE-IVD. 96-test microplate. Product Characteristics
Product Components
|
Product ApplicationsClinical suspicion of HIT during heparin therapy. Heparin-dependent antibodies of the IgG isotype are those strongly associated with the clinical diagnosis of HIT. The ZYMUTESTâ„¢ HIA IgG assay offers then a better specificity for the clinical complication of HIT, but it has less sensitivity as cases associated with only IgM and/or IgA isotypes are missed. |